← Leaderboards
Daniel Joseph Cox
University Of Virginia Charlottesville
$12,800,250
Attributed
$14,552,794
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,552,794 · 7
By mechanism
R01$14,205,388 · 4
M01$347,406 · 3
Top collaborators
- Tamara K Oser4 shared
- Chiara Fabris3 shared
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Robert C. Pianta$11,747,919
- Robert L. Chevalier$3,301,352
- Kerry Laing Kilbridge$1,061,295
- Arlene W. Keeling$381,636
- Jeff R Crandall$201,213
Others in their field
Top investigators on “Blood Glucose”
- Rose A Gubitosi-Klug · Case Western Reserve University$56,959,998
- Jose A Luchsinger · Columbia University Health Sciences$47,880,063
- Walter N Kernan · Yale University$42,197,025
- Paul M. Ridker · Brigham And Women'S Hospital$34,275,148
- Katherine M Detre · University Of Pittsburgh At Pittsburgh$33,228,566
- Anastassios G Pittas · Tufts Medical Center$33,034,279
Research focus
Blood GlucoseHypoglycemiaHuman SubjectBehavior TherapyClinical ResearchDiabetes MellitusInternetInsulin Dependent Diabetes MellitusRandomizedGlucoseCostDisease /Disorder Proneness /RiskBehavioral /Social Science Research TagDoseHyperglycemiaInsulinDiabetes ManagementResourcesMorbidity - Disease RateBasePersonsEffective TherapyBehavior ChangeDiabetes Education
Grant awards (37)
Treating early type 2 diabetes by reducing postprandial glucose excursions: A paradigm shift in lifestyle modification$702,972
R01 · FY2025 · DK
Treating early type 2 diabetes by reducing postprandial glucose excursions: A paradigm shift in lifestyle modification$670,034
R01 · FY2024 · DK
Treating early type 2 diabetes by reducing postprandial glucose excursions: A paradigm shift in lifestyle modification$706,296
R01 · FY2023 · DK
Treating early type 2 diabetes by reducing postprandial glucose excursions: A paradigm shift in lifestyle modification$732,686
R01 · FY2022 · DK · contact PI
Treating Type 2 Diabetes by Reducing Postprandial Glucose Elevations: A Paradigm Shift in Lifestyle Modification$679,586
R01 · FY2019 · DK · contact PI
Treating Type 2 Diabetes by Reducing Postprandial Glucose Elevations: A Paradigm Shift in Lifestyle Modification$632,237
R01 · FY2018 · DK · contact PI
Treating Type 2 Diabetes by Reducing Postprandial Glucose Elevations: A Paradigm Shift in Lifestyle Modification$698,404
R01 · FY2017 · DK · contact PI
Treating Type 2 Diabetes by Reducing Postprandial Glucose Elevations: A Paradigm Shift in Lifestyle Modification$695,324
R01 · FY2016 · DK · contact PI
Identify Driving Risk Factors in T1DM and their Reduction via Behav Intervention$669,453
R01 · FY2012 · DK · contact PI
Identify Driving Risk Factors in T1DM and their Reduction via Behav Intervention$668,481
R01 · FY2011 · DK · contact PI
Identify Driving Risk Factors in T1DM and their Reduction via Behav Intervention$675,229
R01 · FY2010 · DK · contact PI
Identify Driving Risk Factors in T1DM and their Reduction via Behav Intervention$154,000
R01 · FY2010 · DK · contact PI
Identify Driving Risk Factors in T1DM and their Reduction via Behav Intervention$662,184
R01 · FY2009 · DK · contact PI
Identify Driving Risk Factors in T1DM and their Reduction via Behav Intervention$642,901
R01 · FY2008 · DK · contact PI
HYPOGLYCEMIA & DRIVING:INCIDENCE, MECHANISMS, PREVENTION$669,404
R01 · FY2006 · DK · contact PI
HYPOGLYCEMIA &DRIVING:INCIDENCE, MECHANISMS, PREVENTION$653,993
R01 · FY2005 · DK
Treatment of Early Childhood Constipation and Encopresis$397,231
R01 · FY2005 · HD
HYPOGLYCEMIA &DRIVING:INCIDENCE, MECHANISMS, PREVENTION$632,706
R01 · FY2004 · DK
Treatment of Early Childhood Constipation and Encopresis$395,882
R01 · FY2004 · HD
HYPOGLYCEMIA &DRIVING:INCIDENCE, MECHANISMS, PREVENTION$636,304
R01 · FY2003 · DK
Treatment of Early Childhood Constipation and Encopresis$402,988
R01 · FY2003 · HD
Treatment of Early Childhood Constipation and Encopresis$384,133
R01 · FY2002 · HD
SEVERE HYPOGLYCEMIA: RISKS AND PREVENTION I$48,533
M01 · FY2002 · RR
SEVERE HYPOGLYCEMIA: ITS RISKS &PREVENTION PHASE II, III, IV$48,533
M01 · FY2002 · RR
SEVERE HYPOGLYCEMIA--ITS RISKS AND PREVENTION--PHASE II$48,533
M01 · FY2002 · RR
Treatment of Early Childhood Constipation and Encopresis$392,553
R01 · FY2001 · HD
SEVERE HYPOGLYCEMIA: ITS RISKS &PREVENTION PHASE II, III, IV$48,533
M01 · FY2001 · RR
SEVERE HYPOGLYCEMIA--ITS RISKS AND PREVENTION--PHASE II$48,533
M01 · FY2001 · RR
SEVERE HYPOGLYCEMIA: RISKS AND PREVENTION I$48,533
M01 · FY2001 · RR
TREATMENT OF EARLY CHILDHOOD CONSTIPATION AND ENCOPRESIS$355,847
R01 · FY2000 · HD
SEVERE HYPOGLYCEMIA--RISKS AND PREVENTION$294,560
R01 · FY2000 · DK
SEVERE HYPOGLYCEMIA--ITS RISKS AND PREVENTION--PHASE II$28,104
M01 · FY2000 · RR
SEVERE HYPOGLYCEMIA: ITS RISKS &PREVENTION PHASE II, III, IV$28,104
M01 · FY2000 · RR
SEVERE HYPOGLYCEMIA: RISKS AND PREVENTION I$0
M01 · FY2000 · RR
SEVERE HYPOGLYCEMIA: ITS RISKS &PREVENTION PHASE II, III, IV$0
M01 · FY2000 · RR
SEVERE HYPOGLYCEMIA--ITS RISKS AND PREVENTION--PHASE II$0
M01 · FY2000 · RR
SEVERE HYPOGLYCEMIA: RISKS AND PREVENTION I$0
M01 · FY2000 · RR